To estimate factors associated to illicit drug use among patients with mental illness in Brazil according to gender.
INTRODUCTION
Illicit drug abuse and dependence are important public health issues worldwide. Data from the World Health Organization (WHO) show that substance use and mental disorders are, together, the number one cause of years lost due to disability (22% of YLD) and the 15 highest cause of disability-adjusted life years (7.4% of DALYs) 32 . During 2010, 3.4% to 6.6% of the worldwide adult population used some illicit substance, and 10% to 13% of this population demonstrated abuse or dependence. Illicit drug use greatly increases the probability of having health risk behavior and is associated with higher rates of overdose, suicide, violence, HIV infection, and sexual risk behavior 26, 30 . Injecting drugs further increases these risks, and needle sharing may transmit blood-borne diseases among users 30 .
The association between mental disorders and psychoactive substance use has been frequently discussed in the literature since the 1990s. Despite varying prevalence rates in different countries 22 , high prevalence of illicit drug use in psychiatric patients is evident 2, 14, 18, 23 . Data from the USA indicate that, while 3.7% of the persons without history of mental illness had a history of lifetime drug abuse or dependence, the rate was 14.7% (OR = 4.7; 95%CI 3.5-6.3) among those with any lifetime mental illness diagnosis 23 . In the United Kingdom, Fisher et al. 6 identified that psychiatric patients had twice the chance of developing a substance use disorder as compared to those with no mental disorders. A study carried out in São Paulo, Brazil, showed that 4.7% of adult patients with severe mental illness (SMI) in treatment fulfilled criteria for abuse or dependence of illicit drug use and 8.3% had used an illicit substance in the past year 19 . A current comorbid substance use disorder was present in 11.2% of a sample of outpatients with SMI in Rio de Janeiro, Brazil 31 .
Illicit drug use is associated with multiple factors, including child sexual abuse, parental violence, parents or sibling who also use drugs, and being younger, male, single, and with lower schooling 3, 5 . Similar to the general population, drug use among patients with mental illness is higher among those who are male, younger 3, 11, 12, 18 , single 18 , have family members who use drugs 3 , or have a history of homelessness or incarceration 23 .
There is a remarkable difference in rates of drug use between men and women. Use among women is lower than among men, with differences that vary from a 3:4 ratio in the United States to 1:10 in India and Indonesia 30 , indicating higher vulnerability among men. The only instance in which this ratio is reversed is in the use of tranquilizers and sedatives. Comorbidity between severe mental illness and substance use disorders is more prevalent among men, whereas women with alcohol or drug-associated disorders had twice the risk of having depressive and anxiety disorders when compared to men 29 .
Illicit drug use and mental illness can have a negative impact on health such as reduced adherence to treatment and worsen prognosis, leading to more intensive and expensive treatments in emergency settings 2, 6 . However, few surveys on the association between illicit drug use and mental illness have been conducted in low and middle-income countries 11 . Brazil has scarce published data on illicit drug use among patients with mental illness and no studies with a national representative sample. This study aimed to estimate the risk behavior factors associated with recent illicit drug use among patients with mental illness in Brazil according to gender.
METHODS
We obtained data from a large national multicenter cross-sectional study conducted in 2006. The main objective was to determine the prevalence of infection with HIV, syphilis, and hepatitis B and C in a sample of adult psychiatric patients (18 years of age or older) in treatment in Brazil 20 .
A two-stage sampling procedure was carried out with a random selection of centers in each region followed by random selection of participants within each center 20 . Sample size calculation considered 50% average estimate of the conditions, 0.2% precision, 5% confidence level, and a potential 40% loss. It was proportional to the type of care (hospital or Psychosocial Care Centers [CAPS] ) and to the distribution of AIDS cases in the regions. Among the 3,255 patients recruited, 2,763 (84.9%) were considered eligible as previously described 8 . From these patients, 288 (10.4%) did not participate for various reasons (such as refusal, non-attendance, death), amounting to a 26% loss for the interview, below the initial estimate of 40%. Public outpatient mental health clinics that exclusively treated substance use disorders (CAPS AD) were excluded from the sampling process to prevent the overestimation of the selected risk behaviors or prevalence rates. The study was carried out with 2,475 patients recruited from 11 psychiatric hospitals and 15 public mental health outpatient clinics (CAPS) distributed in the five Brazilian macroregions.
Patients who agreed to participate and were considered eligible underwent a face-to-face interview with a semi-structured questionnaire, tested in a preliminary pilot study 8 , to collect information about health care, behavioral characteristics, and sociodemographic profile. Healthcare professionals who worked at the treatment services administered the interviews. Additional clinical data such as psychiatric diagnosis and treatment characteristics were collected from the medical records. The study included only patients able to provide written informed consent and who were able to answer the questionnaire after the administration of a preliminary assessment adapted from the Mini-Mental State Examination (MMSE). Further details have been previously published 8 .
The outcome of interest for this analysis was recent illicit drug use (i.e., patients that reported using any illicit drug at least once during the 12 months prior to the interview). The illicit drugs considered were marijuana, cocaine, crack, hallucinogens, amphetamines, opiates, solvents, or other non-prescribed or illicit drugs.
Potential explanatory variables were divided into three groups: sociodemographic, clinical characteristics, and risk behavior. Sociodemographic characteristics included age, skin color, marital status, schooling, having an income in the last six months, place of residence, and professing a religion. Median age (40 years old) was used as a cutoff point. Skin color was dichotomized as non-white and white. For marital status, those who were single, separated/divorced, or widowed were grouped into one category. The cutoff point for schooling was five years ( first cycle of elementary school). For housing, those living in houses or apartments were considered stable, while those living in shelters, pensions, hostels, and on streets were grouped as unstable. Clinical characteristics included main psychiatric diagnosis, history of hospitalization, medical comorbidities, and history of sexually transmitted infections (STI). The main psychiatric diagnosis was classified according to the International Classification of Diseases (ICD-10), defined by a psychiatrist as registered in the medical chart. This variable was dichotomized into severe mental illness (SMI) and compared to the other diagnoses. Severe mental illnesses included diagnoses of schizophrenia, bipolar disorders, and depression with psychotic symptoms 25 . History of hospitalization was analyzed by dividing the sample into three categories: those who were hospitalized in one of the participating psychiatric hospitals during the study; those who were under care in CAPS but had a history of any previous hospitalization; and those who were under care in CAPS and had never been hospitalized. Risk behavior characteristics included the following variables: lifetime tobacco use, lifetime alcohol use, history of homelessness, history of physical and sexual violence, history of incarceration, age of first sexual intercourse, number of partners, and practice of unprotected sex. Lifetime risk behavior self-reports have demonstrated reliability 8 . The cutoff point for age at first sexual intercourse was 18 years. Finally, those with two or more lifetime sexual partners were compared to those with only one or no partners, and unprotected sex was defined as not always using condoms in all sexual practices (ever).
Analyses were conducted separately for men and women. Descriptive analyses were carried out and the prevalence of recent illicit drug use was calculated by dividing the number of participants who reported using any illicit drug in the 12 months prior to the interview by the total number of participants, with 95% confidence interval (95%CI). For the univariate analysis, differences in proportion were assessed by Pearson's Chi-square test, and the magnitude of the associations was estimated by the odds ratio (OR) with 95%CI. A multivariate logistic model was used to estimate the independent effect of potential explanatory variables, using a sequential backward elimination method. Variables that presented p < 0.20 in the univariate analysis were initially included. Wald test was used to assess the statistical significance of each variable. Only those with p < 0.05 remained in the final model. Goodness of fit was assessed by the Hosmer-Lemeshow test. For statistical analysis, EpiInfo 7 and Stata 12 were used.
RESULTS
All participants who answered to the questionnaire were included in the study (n = 2,475): 51.6% were women (n = 1,277) and 48.4% were men (n = 1,198). As shown in Table 1 , most men and women were 40 years old or over, single, with no income in the last six months, had stable housing, and professed a religion. Men were more likely than women to be single (75.8%) and to live in unstable housing (17.5%), whereas women were more likely than men to profess a religion (87.8%). Men were also more likely than women to have a severe mental illness diagnosis (61.0%), to be hospitalized during the study period (45.0%), and to have a prior history of hospitalization (34.4%). Overall, high prevalence of self-reported medical comorbidities (45.3%) and history of STI (23.3%) was also found. In addition, men had a higher proportion of tobacco smoking, alcohol drinking, early sexual debut (< 18 years old), more than one lifetime sexual partner, and history of incarceration and homelessness, whereas women had a higher proportion of history of sexual violence and lifetime unprotected sex ( Table 1) .
The overall prevalence of any illicit drug use was 11.4% in the past year and 25.4% during lifetime (Table 2) . Compared to women, men had a higher prevalence of drug use, 17.5% versus 5.6% in the past year and 36.8% versus 14.7% for lifetime, respectively. For both men and women, the substance used with the highest prevalence was marijuana (8.8% in the past year and 21.9% for lifetime), followed by cocaine (3.4%, in the past year and 10.6% for lifetime). Both were more prevalent among men than women. A small proportion of the sample (2.9%) reported lifetime injection drug use, and use of more than one drug was reported by 24.1% of the men and 5.7% of the women. Finally, men had a higher proportion of drug use during sex (13.4%) and exchange of money or drugs for sex (40.4%) compared to women (5.6% and 13.2%, respectively) ( Table 2 ).
In the univariate analysis, most of the variables investigated were statistically associated (p < 0.05) with recent illicit drug use (Table 3) for both men and women, including being younger, having less schooling, previous history of hospitalization, history of STI, and all risk behavior characteristics. On the other hand, being single and having an unstable place of residence were associated with illicit drug use among men only, and not professing a religion and medical comorbidities were associated with women only.
The final multivariate models (Table 4) indicated that age (< 40 years old), history of hospitalization, lifetime tobacco use, lifetime alcohol use, history of incarceration, age at sexual debut (< 18 years old), and number of sexual partners (two or more) remained independently associated (p < 0.05) with illicit drug use for both genders. In addition, not professing a religion also remained statistically significant among women, and lower schooling (< 5 years), history of homelessness, and history of physical violence remained statistically significant among men in the respective final models. Having an SMI diagnosis did not remain significant. 
DISCUSSION
Our study found higher rates of both past year (11.4%) and lifetime (25.4%) illicit drug use among psychiatric patients in relation to the rates in the Brazilian general population according to a household survey on drug use carried out in a similar period (2005) in collaboration with the Brazilian National Department on Drug Policies 1 . Moreover, we found higher proportions of specific drug use compared with the same study 1 in the past year (8.8% and 2.6% for marijuana, 3.4% and 0.7% for cocaine, 2.4% and 1.2% for solvents, 5.4% and 0.1% for crack use, respectively) and lifetime (21.9% and 8.8% for marijuana, 10.6% and 2.9% for cocaine, 9.9% and 6.1% for solvents, 8.6% and 0.7% for crack use, respectively). Higher proportions of illicit drug consumption among psychiatric patients are also found in other countries when compared to the general population, with similar results 2, 6, 14, 18, 23 .. In a study carried out in London, Menezes et al. 18 found that 43.3% of patients with SMI had used any drug during lifetime, and 4.7% of them presented some degree of substance use disorder in the year prior to the study. A review of the published literature on drug use among psychotic patients in the United Kingdom 2 showed prevalence rates varying from 15% to 45% in the past year and from 16% to 68% for lifetime use.
In this study, for all substances, men had higher prevalence of use than women in the past year (marijuana: 14.2% versus 3.7%; cocaine: 5.6% versus 1.4%; solvents: 3.9% versus 0.9%; and crack: 8.8% versus 2.2%, respectively). Menezes et al. 18 found similar results, in which men with SMI were 2.7 times more likely than women to have problems related to drug use. In Brazil, a household survey on drug use also indicated that men had a higher prevalence of use (lifetime) than women (marijuana: 14.3% versus 5.1%; cocaine: 5.4% versus 1.2%; solvents: 10.3% versus 3.3%, respectively)
.
We found that recent illicit drug use has strong and significant associations with alcohol and tobacco use for both men and women. Hasin et al. 10 point out the consistency of associations between drug abuse, nicotine dependence, and alcohol use disorders even when controlling for sociodemographic characteristics and other comorbidities. De Leon et al. 15 indicate that these overlapping disorders have important implications for treatment as patients with SMI who also abuse both alcohol and drugs rarely stop abusing just one of them.
The sociodemographic characteristics associated with drug use among patients with mental illnesses in our study are similar to those found in the general population. Our results are corroborated by previous studies that also indicate higher prevalence among men, younger persons 18 , and those with lower schooling 2, 11 . Lower schooling was associated with recent use among men only, and professing a religion was negatively associated among women only. Professing a religion leads to the adoption of values and behavioral changes that restrict the use of illicit substances, thus acting as a protective factor 24 .
Studies have shown that patients with mental illnesses are sexually active and present high rates of sexual risk behavior 9, 17, 31 . In our study, we observed that recent illicit drug use was associated with younger age at sexual debut and having two or more sexual partners. The use of drugs may increase sexual risk behavior by modifying sexual impulses, thus increasing sexual desire, disinhibiting sexual behavior, or interfering with the practice of safer sex, or all of these 27 .
Illicit drug use was independently associated with a history of incarceration for both genders and with homelessness and physical violence for men. A British survey showed that 16% to 42% of the incarcerated population with psychosis presented dependence on some drug in the year prior to incarceration 4 . Persons with mental illness are more exposed to physical violence than the general population, which in turn is associated with illicit drug use, unstable housing or homelessness 21 , and a history of incarceration 16, 21 . There is evidence that persons with mental illness are most often victims rather than perpetrators of violence 21 . However, some authors have suggested an increase in violent behaviors when illicit drug use is present 2 . These associations suggest the need to introduce new policies to address drug use and the need to prevent violence in mental health programs. We should note the existence of an important initiative in Brazil, named "doctor's office in the street" (Consultório de Rua, in Portuguese), which provides mobile health units for the health care of the homeless and it attempts to link them to health care units for continuous follow-up a .
The association between current psychiatric hospitalization and illicit drug use in the past year found in our study is of clinical and management relevance. First, this finding corroborates the evidence that the association between mental disorders and drug use may lead to results of great severity 2 . Furthermore, according to the studies of Kessler 13 , a history of previous psychiatric hospitalization may indicate higher chances of developing future substance use disorders. The temporal relationship between the emergence of psychiatric and substance use disorders is widely discussed in the literature. Kessler et al. 14 and Swendsen et al. 28 indicate that the emergence of a psychiatric disorder typically precedes substance use disorder. However, in a literature review of studies with patients with schizophrenia, Gregg et al. This study is the first one to assess illicit drug use in a representative sample of psychiatric patients under care in public mental health services in Brazil. However, some limitations must be pointed out. The results presented here may not be generalized to all psychiatric patients because of the exclusion of more severely ill patients who were unable to participate. We did not directly assess psychiatric diagnoses or symptoms, but we rather obtained these data from medical charts. Patients who were treated exclusively at substance use centers (CAPS AD) were excluded, which might have led to the underestimation of the prevalence of illicit drug use among persons with mental illnesses. Despite the odds ratio being an appropriate measure for this study, it can potentially overestimate associations. In addition, the cross-sectional design of the study limits our capacity to establish a direct cause and effect and additional studies are necessary.
Our results have important implications for the psychiatric care in Brazil. The treatment of psychiatric patients who use illicit drugs is a major challenge for mental health services. Often professionals are not prepared to assist these persons, and services are not structured to provide high quality treatment or referral. There is a need for comprehensive integrated services to assist this vulnerable population. Strategies should be gender specific with a particular emphasis on the vulnerability to illicit drug use of men with mental illness.
